Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Patients, carers and advocates say better evidence is needed on the safety of ketamine for depression after long-term use, and that those prescribed it must be closely monitored.

A study undertaken as part of a collaboration between the NIHR Maudsley Biomedical Research Centre (BRC) and NIHR Oxford Health Biomedical Research Centre (BRC), Exploring patients'and carers' views about the clinical use of ketamine to inform policy and practical decisions: mixed-methods study, was published on 30 July in the Royal College of Psychiatrists' BJPsych Open.

The study explored attitudes among four groups: people considering ketamine as an antidepressant, people who have already used ketamine for depression, people with experience of illegal drug use and addiction, and patient advocates and carers. 44 people took part in 21 focus groups, and an online survey captured the views of patients, carers and advocates during a consultation day.

Read more

Similar stories

Healthy Start, Happy Start Study

Research Highlights

Healthy Start, Happy start is a randomised controlled trial that tested the clinical- and cost-effectiveness of a brief parenting programme - Video-feedback Intervention to promote Positive Parenting and Sensitive Discipline (VIPP-SD).

New Way of Understanding Dissociation Could Improve Patient Care

Research Highlights

New research has developed a novel measure of dissociative experiences that share a subjective 'felt sense of anomaly'. This new approach could revolutionise how clinicians understand dissociative experiences across a range of mental health disorders, and how they work with patients with dissociation in the future.

New Analysis Challenges Guidelines on Treating Anorexia Nervosa

Research Highlights

A new analysis, published in The Lancet Psychiatry, has shown a lack of strong evidence to support current guidance on psychological therapies for treating anorexia nervosa over expert treatment as usual.

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Research Highlights

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.

How the brain reorganises old memories when new ones are made

Research Highlights

Researchers have discovered that the arrangement of existing memories in the brain is altered when we embed new memories